TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Psychological resilience
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: fast gait speed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: timed-up-and-go
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: diseased QoL rates
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: urgency of defecation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Mineral loss from lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mineral ion uptake by lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: long-term verbal memory performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: long-term spatial memory performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Compliance with prophylactic antibiotic therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: recurrent infection within 1 month
Endpoint domain: Adverse events/effects
Primary endpoint: Improvement on the Beck Scale for Suicide Ideation
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Improvement on the Beck Hopelessness Inventory
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Reduction in symptoms of depression
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Incidence of post-dural puncture headache
Endpoint domain: Adverse events/effects
Primary endpoint: Efficacy of rivaroxaban compared to enoxaparin
Endpoint domain: Mortality/survival
Primary endpoint: Principal safety outcome (major bleeding events)
Endpoint domain: Adverse events/effects
Primary endpoint: Presence of perilesional fat-sparing rings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in PaCO2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: 6-min walk distance (6MWD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intraventricular hemorrhage Hounsfield unit count
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intraventricular hemorrhage volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Levels of sedation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in systemic oxygen saturations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mastery
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Heart Rate Change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: physiologic effects of aerobic exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in daily FV consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Micronutrient status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in bone markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Mean change in IPSS from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: patellofemoral complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: return to preinjury level of activity
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Fibroid size reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Progesterone level after treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Expression amount of pinopodes after treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of maturation of pinopodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of ECC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fatigue during ECC
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Study retention rates
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Overall abstinence rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean daily quantities of alcohol consumed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum metabolites associated with alcohol intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Newborn ferritin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: CD4 cell count at month 24
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: two-year AIDS-free survival
Endpoint domain: Mortality/survival
Primary endpoint: Obliteration of AVMs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Identification of ureteric stones
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Determination of ureteric obstruction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Speed of cognitive information-processing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Long-term memory
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Reactive anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: LE60
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MQ180
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total LM
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percent change in FEV(1)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: percent change in FVC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: median incremental shuttle walk distance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean SGRQ total score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: mental component score of the SF-36
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: mean urinary flow rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: maximum subtracted voiding pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Reduction in the number of episodes of flatulence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Intentions to engage in condomless sex
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: clinical attachment loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: radiographic bone resorption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: post-operative patient discomfort
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Consensus development around code violations
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Sperm concentrations of <1 x 10(6)/ml
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: vigilance
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Proper MDI-spacer technique
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: unplanned rehospitalisation for cardiovascular reasons
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: mitral valve reintervention
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: oral health behaviors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: GBS colony counts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Prevalence of indoor tanning use
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: LAA wall velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: exercise-induced breathlessness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Total tramadol consumption
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Enamel depth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Enamel surface roughness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IR-HOMA scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: lipid profile modification
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: total cholesterol reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: 10-year risk of CVD reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Safety and tolerability of antiepileptic drugs
Endpoint domain: Adverse events/effects
Primary endpoint: AC levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: F-VAS scores
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: increasing condom use during vaginal and anal sex
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reducing the number of days adolescents were under the influence of drugs or alcohol and had sex without a condom
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: preventing unprotected anal sex at the last sexual intercourse
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fasting blood glucose concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Incidence of recurrent N. gonorrhea and C. trachomatis
Endpoint domain: Adverse events/effects
Primary endpoint: Impairment of psychomotor performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anxiety control
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: tumour ESR1 gene expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: absence of necrosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Height differences of clinical crowns of adjacent teeth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of lower-limb edema
Endpoint domain: Adverse events/effects
Primary endpoint: Running Economy (RE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dual task cost TUGmotor
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dual task cost TUGcognitive
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maintaining a psychologically safe environment
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Identifying and exploring performance gaps
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Emphasizing professionalism error of failing to call for help
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Total number of wheezing days
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Proportion of infants with recurrent wheeze
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Treatment tolerance
Endpoint domain: Adverse events/effects
Primary endpoint: Reduction of antiovarian autoantibodies levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Fat reduction in treated area
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Satisfaction from treatment outcomes
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: IFN‐γ ELISpot responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Vaccine-related adverse reactions
Endpoint domain: Adverse events/effects
Primary endpoint: EEG frequency power magnitude during wrist extension
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NTx
Endpoint domain: Physiological/clinical
Endpoint subdomain: Bone and connective tissue outcomes
Primary endpoint: OHP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Bone and connective tissue outcomes
Primary endpoint: Incidence rate of severe injuries per 1000 football hours
Endpoint domain: Adverse events/effects
Primary endpoint: mean maximal endometrial thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: proportion of women with visible cervical mucus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: sustained depression symptom improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ongoing antidepressant treatment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Peak Systolic Velocity (PSV) for detecting restenosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Self-perceived health
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Disease Response Rate (DRR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of evacuation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: AGACHAN score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: number of visits
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Suppression of testosterone
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Suppression of LH and FSH
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Proportion of women reporting correct placement of seat belts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knowledge of seat belt effectiveness
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Proportion of women receiving information from clinic staff on restraint use
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Rehospitalization rates for psychiatric care
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Drinking
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: ADAS score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: CGIC score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Incidence of accelerated nodulosis
Endpoint domain: Adverse events/effects
Primary endpoint: Number of visits to the ED
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: serum concentration of C-reactive protein
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: high-density lipoprotein
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Correct identification of calorie content
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: muscle activation levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Correct perception of limb position
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Phantom limb sensation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Foundations Index performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time to symptom resolution
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Empathy levels
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Severity‐adjusted 28‐day all‐cause mortality
Endpoint domain: Mortality/survival
Primary endpoint: Fracture strength of porcelain laminates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity of problems in at-risk women
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Sexual dysfunction prevalence
Endpoint domain: Life impact
Endpoint subdomain: Sexual functioning
Primary endpoint: Incidence of myocardial injury
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: overall median grades
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: early postprandial glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Incidence of clinical events (death, myocardial infarction, coronary artery bypass surgery, or repeat PTCA)
Endpoint domain: Mortality/survival
Primary endpoint: degree of improvement on the unpracticed modality
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Hazard detection and reaction time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: unexplained lack of follow-up actions
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: incidence of reperfusion-induced VA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Calf vasoconstrictor response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Gain of neuroeffector transfer function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Office SBP/DBP reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Caller ratings on health literacy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Increase in FOBT testing rates
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Saliva levels of prostaglandins
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Achievement of dry weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cardiovascular tolerability of hemodialysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Median willingness to pay (WTP)
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: mean total cholesterol level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: high-density lipoprotein cholesterol level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: median triglyceride level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Pain reduction after ureteral stent removal
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Breast cancer risk associated with genetically predicted fasting insulin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Breast cancer risk associated with genetically predicted 2-h glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Breast cancer risk associated with genetically predicted BMI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Incidence of postoperative UTI
Endpoint domain: Adverse events/effects
Primary endpoint: Primary occlusion rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Post-intervention hospital stay
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: endogenous DNA damage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adverse effect monitoring utility
Endpoint domain: Adverse events/effects
Primary endpoint: Norwegian Basic Aphasia Assessment repetition score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Verb and Sentence Test score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in mean FMD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Impaired RV function detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: 10-year risk for revision
Endpoint domain: Mortality/survival
Primary endpoint: BMI z score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Child health-related quality of life improvement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Percentage of children becoming UTD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of children receiving 1 or more vaccines
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cost per child brought UTD
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: GHQ scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status